Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1

Virology

Volumn 268, Issue 2, 2000, Pages 281-293

  Egawa, Kiyofumi ^a   Iftner, Angelika ^b   Doorbar, John ^c   Honda, Yumi ^a   Iftner, Thomas ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

DNA replication; HPV 1; Life cycle; Proteins; Transcripts

Indexed keywords

BROXURIDINE; CAPSID PROTEIN; VIRUS DNA;

ADOLESCENT; ARTICLE; BASAL CELL; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; DNA TRANSCRIPTION; GENE AMPLIFICATION; GENETIC ORGANIZATION; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCHOOL CHILD; SKIN EPITHELIUM; VERRUCA VULGARIS; VIRUS REPLICATION; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; HUMAN POLIOVIRUS 1; MIRIDAE; PAPILLOMAVIRUS; VERRUCA;

EID: 0034654435     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0174     Document Type: Article

References (47)

1. Baker C. C., Howley P. M. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6:1987;1027-1035.
2. Barksdale S. K., Baker C. C. Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J. Virol. 67:1993;5605-5616.
3. Böhm S., Wilczynski S. P., Pfister H., Iftner T. The predominant mRNA class in HPV 16-infected genital neoplasias does not encode the E6 or the E7 protein. Int. J. Cancer. 55:1993;791-798.
4. Breitburd F., Croissant O., Orth G. Expression of human papillomavirus type-1 E4 gene products in warts. Steinberg B. M., Bransma J. L., Taichman L. B. Papillomaviruses: Cancer Cells 5. 1987;115-122 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
5. Chow L. T., Reilly S. S., Broker T. R., Taichmann L. B. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J. Virol. 61:1987;1913-1918.
6. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32:1984;219-229.
7. Cox K. H., DeLeon D. V., Angerer L. M., Angerer R. C. Detection of m-RNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol. 101:1984;485-502.
8. Danos O., Katinka M., Yaniv M. Human papillomavirus 1a complete DNA sequence: A novel type of genome organization among papova viridae. EMBO J. 1:1982;231-236.
9. De Bruijn M. L. H., Greenstone H. L., Vermeulen H., Melief C. J. M., Lowy D. R., Schiller J. T., Kast W. M. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology. 230:1998;371-376.
10. de Villiers E-M. HPV types in human disease. Gross G., von Krogh G. Human Papillomavirus Infection in Dermatovenereology. 1997;101-115 CRC Press, Boca Raton.
11. Doorbar J., Campbell D., Grand R. J. A., Gallimore P. H. Identification of the human papillomavirus-1a E4 gene products. EMBO J. 5:1986;355-362.
12. Doorbar J., Evans H. S., Coneron I., Crawford L. V., Gallimore P. H. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies. EMBO J. 7:1988;825-833.
13. Doorbar J., Foo C., Coleman N., Medcalf L., Hartley O., Prospero T., Napthine S., Sterling J., Winter G., Griffin H. Characterization of events during the late stage of HPV 16 infection in vivo using high-affinity synthetic fabs to E4. Virology. 238:1997;40-52.
14. Doorbar J., Gallimore P. H. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J. Virol. 61:1987;2793-2799.
15. Dürst M., Glitz D., Schneider A., zur Hausen H. Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization. Virology. 189:1992;132-140.
16. Egawa K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: A classification of inclusion warts according to clinical features, histology and associated HPV types. Br. J. Dermatol. 130:1994;158-166.
17. Egawa K., Shibasaki Y., de Villiers E.-M. Double infection with human papillomavirus 1 and human papillomavirus 63 in single cells of a lesion displaying only a human papillomavirus 63-induced cytopathogenic effect. Lab. Invest. 69:1993;583-588.
18. Egawa K., Delius H., Matsukura T., Kawashima M., de Villies E.-M. Two novel types of human papillomavirus, HPV 63 and HPV 65: Comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology. 94:1994;789-799.
19. Frattini M. G., Lim H. B., Laimins L. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. USA. 93:1996;3062-3067.
20. Galloway D. A., McDougall J. K. Human papillomaviruses and carcinomas. Adv. Virus Res. 37:1989;125-171.
21. Gratzner H. G. Monoclonal antibody to 5-bromo- and 5-iododepxyuridine: A new reagent for detection of DNA replication. Science. 218:1982;474-475.
22. Grußendorf E.-I., zur Hausen H. Localization of viral DNA-replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papillomavirus type 1. Arch. Derm. Res. 264:1979;55-63.
23. Hagensee M. E., Yaegashi N., Galloway D. A. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:1993;315-322.
24. Higgins G. D., Uzelin D. M., Phillips G. E., McEvoy P., Marin R., Burrell C. J. Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: Evidence for promoter usage within the E7 open reading frame during epithelial differentiation. J. Gen. Virol. 73:1992;2047-2057.
25. Hsu S.-M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complexes (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
26. Iftner T., Oft M., Boehm S., Wilczynski S. P., Pfister H. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J. Virol. 66:1992;4639-4646.
27. Iftner T., Boehm S., Oft M., Wilczynski S. P., Pfister H. Expression of the E6 and E7 genes of human papillomaviruses in tumor of different dignity. Stanley M. A. Immunology of Human Papillomaviruses. 1994;Plenum, New York.
28. Iftner, T. 1999. unpublished results.
29. Jablonska S., Orth G., Obalek S., Croissant O. Cutaneous warts. Clinical, histologic, and virologic correlations. Jablonska S., Orth G. Clinics in Dermatology. 1985;71-82 Lippincott, Philadelphia.
30. Jareborg N., Burnett S. Immunofluorescent detection of bovine papillomavirus E4 antigen in the cytoplasm of cells permissive in vitro for viral DNA amplification. J. Gen. Virol. 72:1991;2269-2274.
31. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D. R., Schiller J. T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:1993;6929-6936.
32. Laimins L. A. Human papillomaviruses target differentiating epithelia for virion production and malignant conversion. Semin. Virol. 7:1996;305-313.
33. Lin Y.-L., Borenstein R., Selvakumar R., Ahmed R., Wettstein F. O. Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J. Virol. 67:1993;382-389.
34. Liu W. J., Gissmann L., Sun X. Y., Kanjanahaluethai A., Mueller M., Doorbar J., Zhou J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology. 227:1997;474-483.
35. Oft M., Boehm S., Wilczynski S. P., Iftner T. Expression of the different viral mRNAs of human papillomavirus 6 in a squamous cell carcinoma of the bladder and the cervix. Int. J. Cancer. 53:1993;924-931.
36. Palermo-Dilts D. A., Broker T. R., Chow L. T. Human papillomavirus type 1 produces redundant as well as polycistronic mRNA in plantar warts. J. Virol. 64:1990;3144-3149.
37. Rashad A. L. Radioautographic evidence of DNA synthesis in well-differentiated cells of human skin papillomas (verruca vulgaris). J. Invest. Dermatol. 53:1969;356-362.
38. Roden R. B. S., Greenstone H. L., Kirnbauer R., Brooy F., Jessie J., Lowy D. R., Schiller J. T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70:1996;5875-5883.
39. Rogel-Gaillard C., Breitburd F., Orth G. Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular locations when transiently expressed in vitro. J. Virol. 66:1992;816-823.
40. Ruesch M. N., Stubenrauch F., Laimins L. A. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72:1998;5016-5024.
41. Schiller J. T., Roden R. B. S. Lacey C. Papillomavirus Reviews: Current Research on Papillomaviruses. 1996;101-111 Leeds Univ. Press, Leeds.
42. Schmitt A., Harry J. B., Rapp B., Wettstein F. O., Iftner T. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J. Virol. 68:1994;7051-7059.
43. Schmitt A., Rochat A., Zeltner R., Borenstein L., Barrandon Y., Wettstein F. O., Iftner T. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 70:1996;1912-1922.
44. Thomas J. T., Laimins L. A., Ruesch M. N. Perturbation of cell cycle control by E6 and E7 oncoproteins of human papillomaviruses. Papillomavirus Rep. 9:1998;59-64.
45. Zeltner R., Borenstein L. A., Wettstein F. O., Iftner T. Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits. J. Virol. 68:1994;3620-3630.
46. Zhou J., Stenzel D. J., Sun X.-Y., Frazer I. C. H. Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J. Gen. Virol. 74:1993;763-768.
47. zur Hausen H. Papillomavirus infections - A major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.